AN ILLUSTRATIVE STATISTICAL-ANALYSIS OF CUTOFF-BASED RANDOMIZED CLINICAL-TRIALS

被引:14
作者
CAPPELLERI, JC [1 ]
TROCHIM, WMK [1 ]
机构
[1] CORNELL UNIV,ITHACA,NY 14853
关键词
CUTOFF-BASED RCTS; CLINICAL TRIALS; RANDOMIZATION; EXPERIMENTAL DESIGNS; QUASI-EXPERIMENTAL DESIGNS; METHODOLOGY;
D O I
10.1016/0895-4356(94)90007-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cutoff-based randomized clinical trials (RCTs) are designed to balance ethical and scientific concerns. Patients scoring below a cutoff score on a baseline measure (i.e. the least severely ill) are assigned to the control-treated group, those scoring above a second cutoff score (i.e. the most severely iii) are assigned to the test-treated group, and those scoring within the interval (i.e. the moderately ill) are randomly assigned. This paper provides a formal illustration on the statistical analysis of cutoff-based RCTs using data from the Xanax Cross-National Collaborative Study. To overcome problems specific to cutoff-based designs, we generally recommend a backward elimination approach that tests interactions before main effects.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 50 条
  • [41] Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
    CK Haddock
    WSC Poston
    PL Dill
    JP Foreyt
    M Ericsson
    International Journal of Obesity, 2002, 26 : 262 - 273
  • [42] Effect of physician profiling on utilization - Meta-analysis of randomized clinical trials
    Balas, EA
    Baren, SA
    Brown, GD
    Ewigman, BG
    Mitchell, JA
    Perkoff, GT
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (10) : 584 - 590
  • [43] Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer
    Zakeri, Kaveh
    Rose, Brent S.
    D'Amico, Anthony V.
    Jeong, Jong-Hyeon
    Mell, Loren K.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 (01) : 114 - 119
  • [44] Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials
    Haddock, CK
    Poston, WSC
    Dill, PL
    Foreyt, JP
    Ericsson, M
    INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (02) : 262 - 273
  • [45] Health-related quality of life in phase III cancer clinical trials: From questionnaire administration to statistical analysis
    Fiteni, Frederic
    Anota, Amelie
    Westeel, Virginie
    Bonnetain, Franck
    BULLETIN DU CANCER, 2015, 102 (04) : 360 - 366
  • [46] Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review
    Thompson, P. A.
    Wright, D. E.
    Counsell, C. E.
    Zajicek, J.
    INTERNATIONAL PSYCHOGERIATRICS, 2012, 24 (05) : 689 - 697
  • [47] COMBINATIONS OF LIFE-STYLE MODIFICATION AND DRUG-TREATMENT IN MANAGEMENT OF MILD-MODERATE HYPERTENSION - A REVIEW OF RANDOMIZED CLINICAL-TRIALS
    CUTLER, JA
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1993, 15 (06) : 1193 - 1204
  • [48] Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information Part 2: Statistical considerations
    Ball, Greg
    Piller, Linda B.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 : S5 - S7
  • [49] MEASURING ACTIVITIES IN CLINICAL-TRIALS USING RANDOM WORK SAMPLING - IMPLICATIONS FOR COST-EFFECTIVENESS ANALYSIS AND MEASUREMENT OF THE INTERVENTION
    ODDONE, E
    WEINBERGER, M
    HURDER, A
    HENDERSON, W
    SIMEL, D
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (08) : 1011 - 1018
  • [50] Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials
    Volpe, Massimo
    Tocci, Giuliano
    Sciarretta, Sebastiano
    Verdecchia, Paolo
    Trimarco, Bruno
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2009, 27 (05) : 941 - 946